Table. 1 Patient characteristics: non-early group vs. early group
OverallN = 308 | Non-early groupN = 213 | Early groupN = 95 | P value | |
|---|---|---|---|---|
Age, years | 75 (66–82) | 74 (66–81) | 75 (66–83) | 0.495 |
Male, n (%) | 208 (67.5%) | 144 (67.6%) | 64 (67.4%) | 0.967 |
Body mass index, kg/m2 | 22.7 (19.6–25.3) | 22.5 (19.4–25.3) | 22.9 (20.1–25.2) | 0.824 |
Patient category | 0.699 | |||
Non-scheduled surgery, n (%) | 78 (25.3%) | 51 (23.9%) | 27 (28.4%) | |
Scheduled surgery, n (%) | 36 (11.7%) | 25 (11.7%) | 11 (11.6%) | |
Medical, n (%) | 194 (63.0%) | 137 (64.3%) | 57 (60.0%) | |
APACHE II score at ICU admission | 24 (19–30) | 25 (20–30) | 23 (18–27) | 0.039 |
SOFA score at AF onset | 8 (6–11) | 8 (6–12) | 7 (5–9) | 0.009 |
Chronic hemodialysis, n (%) | 17 (5.5%) | 14 (6.6%) | 3 (3.2%) | 0.226 |
CHA2DS2-VASc score | 3 (2–4) | 3 (2–4) | 3 (2–4) | 0.859 |
CHA2DS2-VASc ≥ 2, n (%) | 244 (79.2%) | 169 (79.3%) | 75 (79.0%) | 0.937 |
HAS-BLED bleeding risk score | 2 (1–3) | 2 (1–3) | 2 (1–3) | 0.562 |
HAS-BLED ≥ 3, n (%) | 82 (26.6%) | 58 (27.2%) | 24 (25.3%) | 0.718 |
Infection at AF onset, n (%) | 230 (74.7%) | 157 (73.7%) | 73 (76.8%) | 0.559 |
From ICU admission to AF onset, hours | 28.8 (15.3–113.8) | 27.0 (13.9–115.1) | 31.5 (15.4–113.8) | 0.384 |
Treatment at AF onset | ||||
Mechanical ventilation, n (%) | 212 (68.8%) | 148 (69.5%) | 64 (67.4%) | 0.711 |
Renal replacement therapy, n (%) | 83 (27.0%) | 67 (31.5%) | 16 (16.8%) | 0.008 |
Vasopressors, n (%) | 157 (51.0%) | 107 (50.2%) | 50 (52.6%) | 0.698 |
Inotropes, n (%) | 39 (12.7%) | 25 (11.7%) | 14 (14.7%) | 0.465 |